The orphan G protein-coupled receptor, GPR139, is expressed in the hypothalamus and is involved in the regulation of body mass, blood glucose, and insulin
Copyright © 2022 Elsevier B.V. All rights reserved..
GPR139 is an orphan G-protein-coupled receptor that is expressed in restricted areas of the nervous system, including the hypothalamus. In this study, we hypothesized that GPR139 could be involved in the regulation of energy balance and metabolism. In the first part of the study, we confirmed that GPR139 is expressed in the hypothalamus and particularly in proopiomelanocortin and agouti-related peptide neurons of the mediobasal hypothalamus. Using a lentivirus with a short-hairpin RNA, we inhibited the expression of GPR139 bilaterally in the mediobasal hypothalamus of mice. The intervention promoted a 40% reduction in the hypothalamic expression of GPR139, which was accompanied by an increase in body mass, a reduction in fasting blood glucose levels, and an increase in insulin levels. In the hypothalamus, inhibition of GPR139 was accompanied by a reduction in the expression of orexin. As previous studies using a pharmacological antagonist of orexin showed a beneficial impact on type 2 diabetes and glucose metabolism, we propose that the inhibition of hypothalamic GPR139 could be acting indirectly through the orexin system to control systemic glucose and insulin. In conclusion, this study advances the characterization of GPR139 in the hypothalamus, demonstrating its involvement in the regulation of body mass, blood insulin, and glycemia.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:792 |
---|---|
Enthalten in: |
Neuroscience letters - 792(2023) vom: 01. Jan., Seite 136955 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Nogueira, Pedro A S [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 29.11.2022 Date Revised 24.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.neulet.2022.136955 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM348610742 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM348610742 | ||
003 | DE-627 | ||
005 | 20231226040650.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.neulet.2022.136955 |2 doi | |
028 | 5 | 2 | |a pubmed24n1161.xml |
035 | |a (DE-627)NLM348610742 | ||
035 | |a (NLM)36347339 | ||
035 | |a (PII)S0304-3940(22)00516-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Nogueira, Pedro A S |e verfasserin |4 aut | |
245 | 1 | 4 | |a The orphan G protein-coupled receptor, GPR139, is expressed in the hypothalamus and is involved in the regulation of body mass, blood glucose, and insulin |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.11.2022 | ||
500 | |a Date Revised 24.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Elsevier B.V. All rights reserved. | ||
520 | |a GPR139 is an orphan G-protein-coupled receptor that is expressed in restricted areas of the nervous system, including the hypothalamus. In this study, we hypothesized that GPR139 could be involved in the regulation of energy balance and metabolism. In the first part of the study, we confirmed that GPR139 is expressed in the hypothalamus and particularly in proopiomelanocortin and agouti-related peptide neurons of the mediobasal hypothalamus. Using a lentivirus with a short-hairpin RNA, we inhibited the expression of GPR139 bilaterally in the mediobasal hypothalamus of mice. The intervention promoted a 40% reduction in the hypothalamic expression of GPR139, which was accompanied by an increase in body mass, a reduction in fasting blood glucose levels, and an increase in insulin levels. In the hypothalamus, inhibition of GPR139 was accompanied by a reduction in the expression of orexin. As previous studies using a pharmacological antagonist of orexin showed a beneficial impact on type 2 diabetes and glucose metabolism, we propose that the inhibition of hypothalamic GPR139 could be acting indirectly through the orexin system to control systemic glucose and insulin. In conclusion, this study advances the characterization of GPR139 in the hypothalamus, demonstrating its involvement in the regulation of body mass, blood insulin, and glycemia | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Caloric intake | |
650 | 4 | |a Energy expenditure | |
650 | 4 | |a G-protein-coupled receptor | |
650 | 4 | |a Obesity | |
650 | 4 | |a Proopiomelanocortin | |
650 | 7 | |a Orexins |2 NLM | |
650 | 7 | |a Insulin |2 NLM | |
650 | 7 | |a Blood Glucose |2 NLM | |
650 | 7 | |a Receptors, G-Protein-Coupled |2 NLM | |
650 | 7 | |a Gpr139 protein, mouse |2 NLM | |
650 | 7 | |a Nerve Tissue Proteins |2 NLM | |
700 | 1 | |a Moura-Assis, Alexandre |e verfasserin |4 aut | |
700 | 1 | |a Zanesco, Ariane M |e verfasserin |4 aut | |
700 | 1 | |a Bombassaro, Bruna |e verfasserin |4 aut | |
700 | 1 | |a Gallo-Ferraz, Ana L |e verfasserin |4 aut | |
700 | 1 | |a Simões, Marcela R |e verfasserin |4 aut | |
700 | 1 | |a Engel, Daiane F |e verfasserin |4 aut | |
700 | 1 | |a Razolli, Daniela S |e verfasserin |4 aut | |
700 | 1 | |a Gaspar, Joana M |e verfasserin |4 aut | |
700 | 1 | |a Junior, Jose Donato |e verfasserin |4 aut | |
700 | 1 | |a Velloso, Licio A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Neuroscience letters |d 1975 |g 792(2023) vom: 01. Jan., Seite 136955 |w (DE-627)NLM000386529 |x 1872-7972 |7 nnns |
773 | 1 | 8 | |g volume:792 |g year:2023 |g day:01 |g month:01 |g pages:136955 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.neulet.2022.136955 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 792 |j 2023 |b 01 |c 01 |h 136955 |